Fulvestrant | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Fulvestrant

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 13 USDMF, 9 CEP/COS, 2 JDMF, 3 EU WC, 8 KDMF, 11 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

99 Drugs in Development

99 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

65 FDF Dossiers, 19 FDA Orange Book, 13 Europe, 6 Canada, 4 Australia, 8 South Africa, 15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAMUSCULAR - 125MG/2.5ML (50MG/ML), SOLUTION;INTRAMUSCULAR - 250MG/5ML (50MG/ML)

RELATED EXCIPIENT COMPANIES

2 Nanjing Well Pharmaceutical, 1 Actylis, 2 Finar, 1 Symrise, 1 TopChem Pharmaceuticals

EXCIPIENTS BY APPLICATIONS

4 Topical, 3 Parenteral, 1 Solubilizers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 102 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 11 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

6 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 4 Others

$ Xls

Filters

Filters

FILTER :

filter Order Code Reset all filters

2 All

01 1Y0001399

02 1Y0001413

filter CAS Number Reset all filters

filter Reference Standard Reset all filters

Product Main Page

01

EDQM, Council of Europe

Fulvestrant for system suitability

AACR Annual meeting

Not Confirmed

02

EDQM, Council of Europe

Fulvestrant

AACR Annual meeting

Not Confirmed

Contact us
to update this info